Intraoperative Neuromonitoring Market Growth Report | Share & Growth Drivers 2027

Intraoperative Neuromonitoring Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Systems, Accessories, Services); Source (Insourced Monitoring, Outsourced Monitoring); Application (Spinal Surgery, Neurosurgery, Vascular Surgery, ENT Surgery, Orthopedic Surgery, Other Surgeries); Modality (Motor Evoked Potentials, Somatosensory Evoked Potentials, Electroencephalography, Electromyography, Brainstem Auditory Evoked Potentials, Visual Evoked Potentials); End User (Hospitals, Ambulatory Surgical Centers); and Geography

Publication Month : May 2020

  • Report Code : TIPRE00004076
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 191
Inquire Before Buy

PRICING

$4550

$2730

[Research Report] The intraoperative neuromonitoring market is expected to reach US$ 4,199.95 million in 2027 from US$ 2,341.92 million in 2019. The market is estimated to grow with a CAGR of 7.6% from 2020 to 2027.

Analyst’s View Point

The medical professionals in charge of conducting and interpreting neuromonitoring during surgical procedures are commonly referred to as intraoperative neuromonitoring (IONM) drivers. These people are frequently highly skilled neurophysiologists or technicians who evaluate the functional integrity of the nervous system in real-time using a variety of monitoring techniques. The capabilities of IONM systems were being improved by ongoing technological advancements, enabling more precise and real-time monitoring during surgical procedures. As surgeons and other healthcare professionals realized how valuable IONM was in lowering the risk of nerve damage during surgeries, particularly complex procedures, its use was expanding. IONM lowers the risk of nerve damage and enhances patient safety by assisting in real-time nervous system monitoring during surgeries. Surgeons use IONM to detect and treat potential surgical complications, such as nerve compression or damage, which improves results and lowers postoperative problems.

The rise in medical procedures has a significant impact on intraoperative neuromonitoring (IONM). As more surgeries are performed, the demand for IONM services to improve patient safety during complex procedures grows. A higher volume of surgeries, particularly those involving delicate neural structures, results in a greater use of IONM. In summary, the rise in the number of medical procedures affects the landscape of interoperative neuromonitoring, propelling advancements, expanding the workforce, and emphasizing the importance of incorporating neuromonitoring into standard surgical practices.

Market Insights

Rising Use of Intraoperative Neuromonitoring 

By giving surgeons real-time feedback during procedures, IONM improves patient safety by assisting them in preventing damage to important brain structures and lowering the possibility of complications. By using IONM to track the nervous system's functional integrity, surgeons can perform precise navigation during procedures, particularly those that involve proximity to important nerves. By reducing the chance of complications like nerve damage, paralysis, or sensory loss both during and after surgery, IONM aids in the early detection of possible problems. The amalgamation of these variables highlights the significance of intraoperative neuromonitoring in contemporary surgical environments, propelling its implementation as a customary practice in numerous procedures.

Future Trend

Technological Advancement in Intraoperative Neuromonitoring

The goal of technological developments in intraoperative neuromonitoring (IONM) is to enhance neural monitoring during surgical procedures in terms of accuracy, dependability, and accessibility. Real-time analysis of complex neural data is made possible by integrating AI and machine learning algorithms, which also improves the overall efficacy of IONM by assisting in the identification of patterns and the prediction of possible problems. Miniaturization advances enable IONM devices to be more compact and minimally invasive, which simplifies their integration into a range of surgical procedures.

A number of businesses were well-known for providing cutting-edge IONM products. For example, Medtronic's NIM Eclipse System is intended to monitor nerves during a range of surgical procedures and give surgeons immediate feedback. It has functions like monitoring for electromyography (EMG) and somatosensory evoked potentials (SEP). Medtronic's NIM Eclipse System is intended to monitor nerves during a range of surgical procedures and give surgeons immediate feedback. It has functions like monitoring for electromyography (EMG) and somatosensory evoked potentials (SSEP).

Report Segmentation and Scope

Product - Based Insights

Based on product, the intraoperative neuromonitoring market is bifurcated into systems, accessories, and services. The systems segment held a larger market share in 2022. By providing real-time monitoring of neural structures during surgery, IONM systems play a critical role in ensuring patient safety. This information is used by surgeons to make precise decisions, reducing the risk of nerve damage and improving overall surgical outcomes. When IONM is combined with surgical navigation systems, it provides a comprehensive view of anatomical structures as well as real-time neural function. This integration improves surgical precision and allows for better decision-making, which in turn drives the growth of the segment.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Source-Based Insights

Based on the source, the global intraoperative neuromonitoring market is classified into insourced monitoring and outsourced monitoring. Intraoperative insourced neuromonitoring involves monitoring a patient's nervous system function during surgery using in-house or insourced resources rather than outsourcing the service to external providers. It helps surgeons assess and protect the patient's neural structures in real time, enhancing the safety of the surgical procedure.

Application-Based Insights

Based on application, the global intraoperative neuromonitoring market is classified into spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries. Intraoperative neuromonitoring (IONM) is critical in spinal surgery for improving patient safety and surgical precision. The primary function of IONM in spinal surgery is to monitor the functional integrity of nerves continuously. This assists surgeons in identifying and avoiding potential spinal nerve damage during procedures, lowering the risk of postoperative neurological deficits. In summary, the role of intraoperative neuromonitoring in spinal surgery is driven by the need to improve surgical precision, increase safety, and prevent nerve damage.

Modality-Based Insights

Based on modality, the global intraoperative neuromonitoring market is classified into motor-evoked potentials, somatosensory evoked potentials, electroencephalography, electromyography, and others. Somatosensory evoked potentials (SSEP) are commonly used in spine surgeries where sensory pathways may be compromised. Monitoring changes in SSEPs aids in the detection of problems during procedures such as spinal fusions or decompressions. SSEPs can also be used to preserve sensory function during surgeries involving peripheral nerves. IONM with SSEPs and TcMEPs has been shown to reduce the incidence of paraplegia during surgery during idiopathic scoliosis fusion (ISF). Furthermore, IONM combined with SSEPs and EEG can be used during carotid endarterectomy to alert the surgeon to the need for shunting to improve cerebral perfusion and reduce the risk of stroke.

End User-Based Insights

Based on end users, the global intraoperative neuromonitoring market is segmented into hospitals, ambulatory surgery centers, and others. Intraoperative neuromonitoring (IONM) is a technique that is widely used in hospitals for a variety of surgical procedures, particularly those involving the nervous system or structures at risk of neural damage. This contributes to the segment's growth.

Intraoperative Neuromonitoring Market, by Product  – 2022 and 2030

Intraoperative Neuromonitoring Market, by Product  – 2022 and 2030
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Regional Analysis

The North American intraoperative neuromonitoring market is segmented into the US, Canada, and Mexico. The IONM market in North America has been steadily growing as people become more aware of the benefits of neuromonitoring in surgical procedures. Major North American hospitals and medical centers have incorporated IONM into their surgical protocols, making it a standard practice in many complex procedures. The North American IONM market is competitive, with numerous companies offering advanced monitoring solutions. Competition is frequently the driving force behind innovation and the development of more user-friendly technologies. In Canada, IONM is commonly used in neurosurgical procedures and spine surgeries where real-time monitoring of neural structures is critical. In Canada, IONM is commonly used in neurosurgical procedures and spine surgeries where real-time monitoring of neural structures is critical. The advancement of Canada's healthcare infrastructure has facilitated the incorporation of advanced medical technologies, such as IONM, into routine surgical practices. Because it reduces the risk of complications and improves outcomes, IONM has become a standard of care in many surgical procedures, particularly those involving delicate neural structures. Mexico has been investing in expanding and improving its healthcare infrastructure, which may encourage the use of advanced medical technologies such as intraoperative neuromonitoring. Similar to trends in other regions, IONM is likely to find applications in neurosurgery and orthopedic surgeries in Mexico to improve patient safety during procedures involving the nervous system or spine. The extent of IONM adoption in Mexico may be influenced by factors such as technology availability, healthcare professional awareness, and healthcare facilities' willingness to invest in advanced surgical monitoring. 

Likewise, Asia Pacific will account for the highest CAGR for the intraoperative neuromonitoring market for the forecast period 2020-2030. The Asia-Pacific (APAC) intraoperative neuromonitoring (IONM) market was expanding owing to factors such as increased awareness, technological advancements, and an increase in the number of surgical procedures. Please keep in mind that the situation may have changed, and the information below may no longer reflect current market dynamics. The Asia-Pacific IONM market is expanding, driven by rising demand for advanced healthcare solutions and growing awareness of the benefits of neuromonitoring in surgical procedures. To improve patient safety, major hospitals and healthcare facilities in the Asia-Pacific region have made IONM a standard practice in complex surgeries. In the Asia-Pacific region, where there is a significant need to monitor neural structures during these procedures, IONM is commonly used in orthopedic and spine surgeries. The development of healthcare infrastructure in several Asia-Pacific countries has facilitated the integration of advanced medical technologies such as IONM.

The report profiles leading players operating in the global intraoperative neuromonitoring market. These include Medtronic, Neurosoft, Nihon Kohden Corporation, IntraNerve Neuroscience Holdings, LLC, NuVasive, Inc., Neurovision Medical Products, and Accurate Monitoring, Computational Diagnostics, Inc. (CDI), inomed Medizintechnik GmbH, and SpecialtyCare.

Brainlab, a digital medical technology company, announced the acquisition of Dr. Langer Medical GmbH in September 2022. The family-owned Company, based in Waldkrich, Germany, specializes in the development of intraoperative neuromonitoring solutions and related equipment for surgical interventions.

WISE, a medical device company, received FDA approval for its WISE Cortical Strip, a single-use device for neuromonitoring, in December 2022. The new device is intended for Intra Operative Neurophysiological Monitoring (IONM) from the brain's surface. It is claimed to be the first FDA-approved product in the Company's WISEneuro Monitoring product portfolio.

In April 2021, Elevation EP, LLC, a Texas-based IONM service provider, was acquired by Assure Holdings Corp., a provider of intraoperative neuromonitoring services. The acquisition is consistent with the Company's strategic plan to accelerate scale by supplementing organic growth with selective M&A opportunities.

Company Profiles

  • Medtronic
  • Neurosoft
  • Nihon Kohden Corporation
  • IntraNerve Neuroscience Holdings, LLC
  • NuVasive, Inc.
  • Neurovision Medical Products.
  • Accurate Monitoring
  • Computational Diagnostics, Inc. (CDI)
  • inomed Medizintechnik GmbH
  • SpecialtyCare
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product ; Source ; Application ; Modality ; End User ; and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What is intraoperative neuromonitoring?

Intraoperative neurophysiological monitoring (IOM) is an integral part of most of the surgical procedures. It has been widely used to prevent the neurological damage caused during number of surgeries, identify neural structures and thereby prevent post-operative impairments. IOM employs a wide range of modalities, which includes motor evoked potentials (MEPs), somatosensory evoked potentials (SSEPs), electroencephalography (EEG), electromyography, brainstem auditory evoked potentials (BAEPs), and visual evoked potentials (VEPs).

What are the driving factors for the intraoperative neuromonitoring market across the globe?

Rising incidences of neurological disorders and increasing technological advancements in the field of neuromonitoring are expected to propel the growth of the market.

What are the factors that are hampering the intraoperative neuromonitoring market?

Lack of skilled professionals is the major factor hindering the market growth. For instance, as per a study by the American Association of Neurological Surgeons, an estimated 22.6 million patients suffer from neurological disorders or injuries. Every year, and around 13.8 million require surgery. In addition, approximately 23,300 additional neurosurgeons are required to address over 5 million essential neurosurgical cases, mostly in low and middle-income countries.

The List of Companies - Intraoperative Neuromonitoring Market

  1. Accurate Monitoring LLC
  2. Computational Diagnostics, Inc.
  3. Intranerve, LLC
  4. inomed Medizintechnik GmbH
  5. Medtronic
  6. Moberg Research Inc.
  7. Natus Medical Incorporated
  8. Nihon Kohden Corporation
  9. NuVasive Inc.
  10. SpecialityCare

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Intraoperative Neuromonitoring Market